Supported by surgeons from
3D surgical roadmaps built from standard MRI. Disease extent, organ relationships, and dissection paths — before the first incision.
Automated organ segmentation at sub-millimeter resolution. Uterus, ovaries, bowel, bladder, ureters — with disease mapping for endometriosis, fibroids, and pelvic pathology. Surgeons focus on decisions, not reconstruction.
Interactive 3D review with the surgical team. Toggle tissues, isolate organs, zoom into disease margins. Dissection line, what to cut, what to preserve — planned before the case begins.
The 3D map stays live in the OR via console or display. Spatial reference throughout the procedure.
*Prospective validation study (n=27 endometriosis cases)
Know the complete extent of disease across compartments. No more discovering involvement mid-procedure.
Measured distances between disease and ureters, bowel, bladder. Know the high-risk zones in advance.
Dissection strategy informed by 3D anatomy. Decide the access path, sequence, and team requirements in advance.
Share the 3D roadmap with urology, colorectal, and anesthesia. Everyone sees the same anatomy before the case.
XENA procedures qualify under existing CPT billing codes. Generates revenue for the department and surgeons, not cost.
Show patients their own 3D anatomy. A clearer explanation improves understanding, consent, and satisfaction.
"XENA gave me a level of pre-operative understanding I've never had before. I could see exactly where the disease was and plan my approach with real confidence."
"The 3D reconstruction adds a dimension that radiology reports alone can't capture. It changes the conversation between radiologist and surgeon entirely."
Deep infiltrating endometriosis mapping across bowel, bladder, and uterosacral ligaments.
Adenomyoma detection and segmentation within the uterine wall for treatment planning.
Fibroid mapping for myomectomy. Size, location, and vascular relationships in 3D.
Ovarian masses, tumor margins, lymph node mapping, and resection planning.
Urology, colorectal, abdominal. Same architecture, new anatomies.
XENA learns anatomy from every MRI it processes. Organ boundaries. Tissue planes. Disease patterns. Every case improves the model.
Endometriosis today. Fibroids, adenomyosis, and oncology extend the same foundation. Each new disease builds on the last.
A 3D disease map. A surgical plan with measurements. Intraoperative guidance in the OR.
Every output is reviewed by a US board-certified radiologist before it reaches the surgeon. HIPAA compliant. Built for FDA clearance.
Every procedure starts with one surgeon mentally reconstructing a three-dimensional disease from two-dimensional imaging slices. No system verifies it. No standard governs it.
70 million soft-tissue surgeries a year in the US. Planned from 2D imaging. 1 in 5 complex cases encounter findings that change the approach mid-procedure. The mortality gap between surgeons performing the same procedure is 5.2×. 3.3 million robotic procedures a year — outcomes still depend on the surgeon.
The limiting factor was never dexterity. It was always the decision.
XENA exists to close that gap. Our founder started this company after her own endometriosis surgeries exposed how little intelligence exists in surgical planning. The technology should have been there. It wasn't.
Birkmeyer et al., NEJM, 2013.
We're running prospective validation studies with leading surgical centers. If you're a surgeon or researcher, we'd like to hear from you.
Join the Study Request White PaperLeave your email and we'll be in touch.